Our mission is to conduct effective advocacy for public policies that encourage the discovery of important, new medicines for patients by biopharmaceutical research companies. To accomplish this mission, we are dedicated to achieving these goals in Washington, D.C. and across the country.

Featured Blogs

Key election year voter insights

Tom Wilbur
Tom Wilbur
Public polling continues to tell the same story about what’s really driving decisions at the polls this year — namely, inflation and the economy.

The hidden bill patients don’t know they are paying

Nicole Longo
Buy low, sell high. That’s the name of the game for large hospitals participating in the 340B Drug Pricing Program – and patients end up picking up part of the tab.

How government price setting fails to address systemic health care inequities

Headshot of Reid Porter, Senior Director of State Public Affairs at PhRMA
Reid Porter
Lowering prescription drug costs for patients and making access to medicines more equitable are two important priorities for America’s biopharmaceutical research companies.

This website uses cookies and other tracking technologies to optimize performance, preferences, usage, and statistics. By clicking “Accept All”, you consent to store on your device the cookies and other tracking technologies that require consent. You can tailor or change your preferences by clicking “Manage My Cookies”. You can check our privacy policy for more information.